Jump to content

Anthony Gill (professor): Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
No edit summary
 
(43 intermediate revisions by 22 users not shown)
Line 1: Line 1:
{{Use dmy dates|date=April 2022}}

{{Infobox person
{{Infobox person
| name = Anthony J Gill
| name = Anthony J Gill
| education = [[Shore School]]
| education = [[Shore School]]
| birth_date = {{birth date and age|1972|08|15}}
| birth_date = {{birth date and age|1972|08|15}}
| image =Anthony Gill University of Sydney.jpg
| image =
| alma_mater = University of Sydney
| alma_mater = University of Sydney
| occupation = Professor, doctor, researcher, author, Pathologist
| occupation = Pathologist
| years_active = 2000 - Present
| years_active = 2000-present
| website = <!-- {{URL|example.com}} -->
| website = <!-- {{URL|example.com}} -->
}}
}}
'''Anthony J Gill''' is an Australian pathologist, professor and medical researcher. He is professor of surgical pathology at the [[University of Sydney]] and the chairman of Australian Pancreatic Cancer Genome Initiative.<ref>{{cite web|url=http://sydney.edu.au/medicine/people/academics/profiles/a.gill.php |title= Professors – University of Sydney}}</ref><ref>{{cite web|title=Australian Pancreatic Genome Initiative |url=http://www.pancreaticcancer.net.au/}}</ref> Most of his research is focused on translating the improved understanding of cancer gained at the basic science level into clinically useful [[Medical test|diagnostic tests]] which can be applied in the routine [[surgical pathology]] laboratory.<ref>{{cite web|title=Google Scholar Citations |url=http://scholar.google.com.au/citations?user=mjRwgw4AAAAJ&hl=en}}</ref> Gill is best known for his description of the class of malignancies now known as [[SDHB|succinate dehydrogenase deficient]] (SDH deficient) - including SDH deficient Renal Carcinoma and SDH deficient Gastrointestinal Stromal Tumour (GIST).<ref name=C>{{cite web|url=http://journals.lww.com/ajsp/Fulltext/2014/12000/Succinate_Dehydrogenase__SDH__deficient_Renal.2.aspx |title=Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity: A Clinicopathologic Series of 36 Tumors From 27 Patients}}</ref><ref name=D>{{cite web|url=http://journals.lww.com/ajsp/Abstract/2010/05000/Immunohistochemistry_for_SDHB_Divides.5.aspx |title=Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types}}</ref> He founded and leads the [http://cancerdiagnosispathology01.businesscatalyst.com/index.html Cancer Diagnosis and Pathology Research Group] at the University of Sydney and [[Kolling Institute of Medical Research]].<ref>{{cite web|title=Cancer Diagnosis and Pathology Group |url=http://www.cancerdxpathology.org.au/}}</ref> In 2017 he was presented with the [[Ramzi Cotran]] young investigator award by the [[United States and Canadian Academy of Pathology]] in recognition of his research.<ref>{{cite web|title=USCAP Ramzi Cotran award |url=http://www.uscap.org/about/uscap-awards/ramzi-s-cotran-young-investigators-award/}}</ref>
'''Anthony J Gill''' {{post-nominals|country=AUS|AM}} is an Australian pathologist, professor of surgical pathology at the [[University of Sydney]] and the chairman of the [[Australian Pancreatic Cancer Genome Initiative]] - part of the [[International Cancer Genome Consortium]].<ref>{{cite web|url=http://sydney.edu.au/medicine/people/academics/profiles/a.gill.php |title= Professors – University of Sydney}}</ref><ref>{{cite web|title=Australian Pancreatic Cancer Genome Initiative |url=http://www.pancreaticcancer.net.au/}}</ref> Most of his research is focused on translating the improved understanding of cancer gained at the basic science level into clinically useful [[Medical test|diagnostic tests]] which can be applied in the routine [[surgical pathology]] laboratory.<ref>{{cite web|title=Google Scholar Citations |url=https://scholar.google.com.au/citations?user=mjRwgw4AAAAJ&hl=en}}</ref>
In addition to his work on pancreatic carcinoma as chairman of the Australian Pancreatic Cancer Genome Initiative, Gill is best known for his description of the class of malignancies now known as [[SDHB|succinate dehydrogenase deficient]] (SDH deficient) - including SDH deficient Renal Carcinoma and SDH deficient Gastrointestinal Stromal Tumour (GIST).<ref name=C>{{cite web|url=http://journals.lww.com/ajsp/Fulltext/2014/12000/Succinate_Dehydrogenase__SDH__deficient_Renal.2.aspx |title=Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity: A Clinicopathologic Series of 36 Tumors From 27 Patients}}</ref><ref name=D>{{cite web|url=http://journals.lww.com/ajsp/Abstract/2010/05000/Immunohistochemistry_for_SDHB_Divides.5.aspx |title=Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types}}</ref> He founded and leads the Cancer Diagnosis and Pathology Research Group<ref>[http://cancerdxpathology.com Cancer Diagnosis and Pathology Group Website]</ref> at the University of Sydney and [[Kolling Institute of Medical Research]].<ref>{{cite web|title=Cancer Diagnosis and Pathology Group |url=http://www.cancerdxpathology.org.au/}}</ref> In 2017 he was presented with the [[Ramzi Cotran]] young investigator award by the [[United States and Canadian Academy of Pathology]] in recognition of his research.<ref>{{cite web |title=USCAP Ramzi Cotran award |url=http://www.uscap.org/about/uscap-awards/ramzi-s-cotran-young-investigators-award/ |access-date=2017-03-11 |archive-url=https://web.archive.org/web/20170309042428/http://www.uscap.org/about/uscap-awards/ramzi-s-cotran-young-investigators-award/ |archive-date=2017-03-09 |url-status=dead }}</ref> Gill is a standing member of the editorial board for the fifth edition of the [[World Health Organization]]/[[International Agency for Research on Cancer]] (IARC) classification of tumors.<ref>{{Cite web|work=WHO Blue Book series |url=http://whobluebooks.iarc.fr/| title= World Health Organization Blue Book Series}}</ref>


== Awards and honors ==
== Awards and honors ==
⚫
*2011 - The [[Benjamin Castleman Award]]<ref>{{Cite web|url=http://www.uscap.org/about/uscap-awards/benjamin-castleman-award/|title=Benjamin Castleman Award|access-date=2017-01-26|archive-url=https://web.archive.org/web/20170309033038/http://www.uscap.org/about/uscap-awards/benjamin-castleman-award/|archive-date=2017-03-09|url-status=dead}}</ref>
*1996 - The Royal North Shore Hospital Medal
⚫
*2011 - The Benjamin Castleman Award<ref>{{Cite web|url=http://www.uscap.org/about/uscap-awards/benjamin-castleman-award/|title= Benjamin Castleman Award}}</ref>
*2011 - The Sir John Loewenthal Medal
*2011 - The Sir John Loewenthal Medal
*2012 - NSW Cancer Institute Wildfire Award
*2012 - NSW Cancer Institute Wildfire Award
*2013 - NSW Premier’s Award for Excellence in Translational Cancer Research
*2013 - NSW Premier’s Award for Excellence in Translational Cancer Research
*2014 - {{Cite web|url=http://sydney.edu.au/szcuf/prize/index.html/| title= The Sir Zelman Cowen Universities Prize for discovery in Medical Research}}
*2014 - The Sir Zelman Cowen Universities Prize for discovery in Medical Research
*2015 - NSW Cancer Institute Wildfire Award
*2015 - NSW Cancer Institute Wildfire Award
*2017 - {{Cite web|url=http://www.uscap.org/about/uscap-awards/ramzi-s-cotran-young-investigators-award/| title= USCAP Ramzi Cotran Award}}
*2017 - USCAP [[Ramzi Cotran | Ramzi Cotran Award]]<ref>{{Cite web|url=http://www.uscap.org/about/uscap-awards/ramzi-s-cotran-young-investigators-award/|title=USCAP Ramzi Cotran Award|access-date=2017-03-11|archive-url=https://web.archive.org/web/20170309042428/http://www.uscap.org/about/uscap-awards/ramzi-s-cotran-young-investigators-award/|archive-date=2017-03-09|url-status=dead}}</ref>
*2018 - [[2018 Queen's Birthday Honours (Australia)|Queen's Birthday Honours]] - appointed Member of the Order of Australia<ref>{{ cite web|url=http://www.gg.gov.au/queens-birthday-2018-honours-list/|title= 2018 Queen's Birthday Honours}}</ref>
*2017 - {{Cite web|url=http://www.iap-aus.org.au/pages/vincent-mcgovern-lectures.html/| title= International Academy of Pathology Vincent McGovern Lecture}}

== Publications ==
*Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and Hyperparathyroidsim-Jaw Tumor (HPT-JT) syndrome related adenomas from sporadic parathyroid adenomas and hyperplasias American Journal of Surgical Pathology 2006 30:1140-1149
*Gill AJ, Chou A, Vilain R, Clarkson A, Lui M, Jin R, Tobias V, Samra J, Goldstein D, Smith C, Sioson L, Parker N, Smith RC, Sywak M, Sidhu SB, Ma Wyatt J, Robinson BG, Benn DE, Clifton-Bligh RJ Immunohistochemistry for SDHB divides Gastrointestinal Stromal Tumors (GISTs) into two distinct types American Journal of Surgical Pathology 2010;34:636-44
*Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, Meyer-Rochow G, Richardson A-L, Sidhu SB, Robinson BG, Clifton-Bligh RJ Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC and SDHD in paraganglioma-phaeochromocytoma syndromes Human Pathology 2010 41:805-814
*Gill AJ, Pachter NS, Clarkson A, Tucker KM, Winship I, Benn DE, Robinson BG, Clifton-Bligh R Renal Tumors and Hereditary Pheochromoytoma-Paraganglioma Syndrome New England Journal of Medicine 2011 364; 9:885-886
*Gill AJ, Chou A, Vilain RE, Clifton-Bligh RJ “Pediatric type” Gastrointestinal stromal tumors are SDHB negative (“type 2”) GISTs American Journal of Surgical Pathology 2011 35:1245–1247
*Gill AJ, Pachter NS, Chou A, Young B, Clarkson A, Tucker KM, Winship IM, Earls P, Benn DE, Robinson BG, Fleming S, Clifton-Bligh RH The renal tumors associated with germline SDHB mutation show distinctive morphology American Journal of Surgical Pathology 2011 35:1578-1585
*Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ, Gill AJ Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase deficient gastrointestinal stromal tumors American Journal of Surgical Pathology 2013; 37:226–233
*Gill AJ, Hes O, Papathomas T, Sedivcova M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, Sioson L, Watson N, Chou A, Paik J, Clifton-Bligh RJ, Robinson BG, Benn DE, Hills H, Maclean F, Niemeijer ND, Vlatkovic L, Hartmann A, Corssmit EPM, van Leenders GJLH, Pryzbycin C, McKenney JK, Magi-Galluzzi C, Yilmaz A, Yu D, Nicoll KD, Yong JL, Sibony M, Yakirevich E, Fleming S, Chow CW, Miettinen M, Michal M, Trpkov Succinate dehydrogenase (SDH) deficient renal carcinoma – a morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients American Journal of Surgical Pathology 2014; 38:1588–1602
*Farzin M, Toon CW, Clarkson A, Sioson L, Watson N, Andrici J, Gill AJ Loss of expression of BAP1 predicts longer survival in mesothelioma Pathology 2015; 47:302-307
*Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, Ahadi MS, Farzin M, Toon CW, Gill AJ Loss of expression of BAP1 is a useful adjunct which strongly supports the diagnosis of mesothelioma in effusion cytology Modern Pathology 2015; 28:1360–1368
*Harrison WJ, Andrici J, Maclean F, Madadi-Ghahan R, Farzin M, Sioson L, Toon CW, Clarkson A, Watson N, Pickett J, Field M, Crook A, Tucker K, Goodwin A, Anderson L, Srinivasan B, Grossman P, Martinek P, Ondic O, Hes O, Trpkov K, Clifton-Bligh RJ, Dwight T, Gill AJ Fumarate hydratase deficient uterine leiomyomas occur in both the syndromic and sporadic settings American Journal of Surgical Pathology 2016; 40:599–607
*Trpkov K, Hess O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, Lüders C, Nesi G, Comperat E, Sibony M, Berney DM, Mehra R, Brimo F, Hartman A, Husain A, Frizzell N, Hills K, Maclean F, Srinivasan B, Gill AJ Fumarate Hydratase-deficient Renal Cell Carcinoma is Strongly Correlated with Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome American Journal of Surgical Pathology 2016;40:865–875


== References ==
== References ==
{{reflist}}
{{reflist}}

{{authority control}}


{{DEFAULTSORT:Gill, Anthony}}
{{DEFAULTSORT:Gill, Anthony}}
[[Category:Members of the Order of Australia]]
[[Category:University of Sydney alumni]]
[[Category:University of Sydney alumni]]
[[Category:University of Sydney faculty]]
[[Category:Academic staff of the University of Sydney]]
[[Category:Australian pathologists]]
[[Category:Australian pathologists]]
[[Category:1972 births]]
[[Category:1972 births]]
[[Category:Living people]]
[[Category:Living people]]
[[Category:People educated at Sydney Church of England Grammar School]]

Latest revision as of 05:00, 20 March 2023

Anthony J Gill
Born (1972-08-15) August 15, 1972 (age 52)
EducationShore School
Alma materUniversity of Sydney
OccupationPathologist
Years active2000-present

Anthony J Gill AM is an Australian pathologist, professor of surgical pathology at the University of Sydney and the chairman of the Australian Pancreatic Cancer Genome Initiative - part of the International Cancer Genome Consortium.[1][2] Most of his research is focused on translating the improved understanding of cancer gained at the basic science level into clinically useful diagnostic tests which can be applied in the routine surgical pathology laboratory.[3]

In addition to his work on pancreatic carcinoma as chairman of the Australian Pancreatic Cancer Genome Initiative, Gill is best known for his description of the class of malignancies now known as succinate dehydrogenase deficient (SDH deficient) - including SDH deficient Renal Carcinoma and SDH deficient Gastrointestinal Stromal Tumour (GIST).[4][5] He founded and leads the Cancer Diagnosis and Pathology Research Group[6] at the University of Sydney and Kolling Institute of Medical Research.[7] In 2017 he was presented with the Ramzi Cotran young investigator award by the United States and Canadian Academy of Pathology in recognition of his research.[8] Gill is a standing member of the editorial board for the fifth edition of the World Health Organization/International Agency for Research on Cancer (IARC) classification of tumors.[9]

Awards and honors

[edit]
  • 2011 - The Benjamin Castleman Award[10]
  • 2011 - The Sir John Loewenthal Medal
  • 2012 - NSW Cancer Institute Wildfire Award
  • 2013 - NSW Premier’s Award for Excellence in Translational Cancer Research
  • 2014 - The Sir Zelman Cowen Universities Prize for discovery in Medical Research
  • 2015 - NSW Cancer Institute Wildfire Award
  • 2017 - USCAP Ramzi Cotran Award[11]
  • 2018 - Queen's Birthday Honours - appointed Member of the Order of Australia[12]

References

[edit]
  1. ^ "Professors – University of Sydney".
  2. ^ "Australian Pancreatic Cancer Genome Initiative".
  3. ^ "Google Scholar Citations".
  4. ^ "Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity: A Clinicopathologic Series of 36 Tumors From 27 Patients".
  5. ^ "Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types".
  6. ^ Cancer Diagnosis and Pathology Group Website
  7. ^ "Cancer Diagnosis and Pathology Group".
  8. ^ "USCAP Ramzi Cotran award". Archived from the original on 9 March 2017. Retrieved 11 March 2017.
  9. ^ "World Health Organization Blue Book Series". WHO Blue Book series.
  10. ^ "Benjamin Castleman Award". Archived from the original on 9 March 2017. Retrieved 26 January 2017.
  11. ^ "USCAP Ramzi Cotran Award". Archived from the original on 9 March 2017. Retrieved 11 March 2017.
  12. ^ "2018 Queen's Birthday Honours".
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Anthony_Gill_(professor)&oldid=1145635919"